VictoryShares International High Div Volatility Wtd ETF CID
Set alert
33.02 USD 0.00 0.00%
At close · Oct 23
33.02 Day range 33.02
30.42 52-week range 34.35
- Open
- 33.02
- Prev close
- 33.02
- Mkt cap
- 17.04M
- Vol
- 286
- Avg vol
- 5.71K
- EPS
- 3.51
- P/E
- 9.40
- Div yield
- 0.00%
More statistics
- Low
- 33.02
- High
- 33.02
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 33.49
- 200-d avg
- 32.51
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 9.40
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 33.49
- 200-day average
- 32.51
About VictoryShares International High Div Volatility Wtd ETF
The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets directly or indirectly in the securities included in the Nasdaq Victory International High Dividend 100 Volatility Weighted Index, an unmanaged, volatility weighted index maintained exclusively by the index provider. The index identifies the 100 highest dividend yielding stocks in the Nasdaq Victory International 500 Volatility Weighted Index.
News
- Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
- Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
- Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
- CID HoldCo, Inc. Provides Market Update and Clarifies Recent Trading Activity
- Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
- 83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
- The EU's Clean Industrial Deal Can't Succeed Without Using a Major Leap in Technology
- CID Boss Maj Magambo Warns: System Will Come For Anyone Planning Chaos in Upcoming Elections
- DPP Abodo Rejects Accusations of Bias; “We Are Not Politically Driven!”
- “You must believe in the patriotism of Uganda”- President Museveni tells CID officers
Your note
Sign in to keep a note on CID — it syncs with the Stock Master app.